The ‘Holy Grail’ of oximetry for critical care is to directly measure oxygen where it is actually used: inside cells. Opticyte is developing the CellSat™ 100, a novel cellular oximeter to address the significant unmet need of monitoring perfusion. Inadequate perfusion can lead to loss of limbs, multiple organ failure, and death. The Company’s new oximeter is poised to revolutionize patient monitoring in ICUs, ORs, and EDs.